CGT

1,342개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,342 programs
CGTStandard DatabasestaleArtiva Biotherapeutics, Inc.Phase 2

Allogeneic NK cells (Allogeneic NK cells)

Refractory Rheumatoid Arthritis (RA); Idiopathic Inflammatory Myopathies (IIMs) · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Recruiting
CGTLimited DatastaleCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Leukemia; Lymphoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
CGTLimited DatastaleLion TCR Pte. Ltd.Phase 1

Biological: TCR-T (Biological: TCR-T)

Recurrent Hepatocellular Carcinoma · Recurrent Hepatocellular Carcinoma

#RecurrentHepatocellularCarcinoma#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTStandard DatabasestaleKite, A Gilead CompanyPhase 2

Bridging Therapy (Bridging Therapy)

Non-Hodgkin Lymphoma · Non-Hodgkin Lymphoma

#Non-HodgkinLymphoma#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Discontinued
CGTStandard DatabasestaleGenentech, Inc.Phase 2

L-Asparaginase (L-Asparaginase)

B Lymphoblastic Leukemia · B Lymphoblastic Leukemia

#BLymphoblasticLeukemia#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Recruiting
CGTLimited DatastaleRoyan InstitutePhase 1

NK cell therapy (NK cell therapy)

Glioblastoma Multiform; Recurrent Glioblastoma · Glioma Glioblastoma Multiforme

#GliomaGlioblastomaMultiforme#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 58Status Active
CGTLimited DatastaleMedigen Vaccine Biologics Corp.Phase 1

Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell, Recombinant Oncolytic HSV-2 Therapeutic Injecta, Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF))

Melanoma Stage IV · Melanoma Stage IV

#MelanomaStageIV#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTStandard DatabasestalePfizerPhase 2

Trimethoprim-sulfamethoxazole (Trimethoprim-sulfamethoxazole)

Chronic Myeloproliferative Disorders; Infection · Chronic Myeloproliferative Disorders

#ChronicMyeloproliferativeDisorde#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
CGTStandard DatabasestaleGeneplus-Beijing Co. Ltd.Phase 2

natural killer cell infusion (natural killer cell infusion)

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood B-Lymphoblastic Lymphoma · Recurrent B-Cell Childhood Acute Lymphob

#RecurrentB-CellChildhoodAcuteLym#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Active
CGTLimited DatastaleMultan Medical And Dental Colle…Phase 2

Isotretinoin (Isotretinoin)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 57Status Discontinued
CGTLimited DatastaleGilead SciencesPhase 1

Ledipasvir-Sofosbuvir (Ledipasvir-Sofosbuvir)

Chronic Hepatitis C · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 57Status Active
CGTStandard DatabasestaleImmunityBio, Inc.Phase 2

IL-15 Superagonist (N-803, N-803 (IL-15 Superagonist))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 57Status Discontinued
CGTLimited DatastaleFate TherapeuticsPhase 1

allogenic NK cells (allogenic NK cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 57Status Active
CGTLimited DatastaleImmunityBio, Inc.Phase 2

ALT-803 (ALT-803)

Melanoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Discontinued
CGTLimited DatastaleMarzieh EbrahimiPhase 1

Allogenic NK cells infusion (Allogenic NK cells infusion)

Neuroblastoma, Recurrent, Refractory; Neuroblastoma (NB) · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 56Status Recruiting
CGTStandard DatabasestaleMinsk Scientific-Practical Cent…Phase 2

Anti-BCMA CAR-T cells (Anti-BCMA CAR-T cells)

Multiple Myeloma Refractory · BCMA

#BCMA#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Active
CGTStandard DatabasestaleJiangsu Topcel-KH Pharmaceutica…Phase 2

CD19 CAR T Arm (CD19 CAR T Arm)

Scleroderma, Systemic · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Recruiting
CGTLimited DatastaleNational Taiwan University Hosp…Phase 1

CD19 Chimeric Antigen Receptor (CAR, CD19 Chimeric Antigen Receptor, CD19 Chimeric Antigen Receptor (CAR) T Cells)

Relapsed/Refractory B-Cell Malignancies · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 56Status Active
CGTLimited DatastaleAllife Medical Science and Tech…Phase 2

Cytokine-induced killer cells (Cytokine-induced killer cells)

Ovarian Carcinoma · Cholangiocarcinoma

#Cholangiocarcinoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Recruiting
CGTLimited DatastaleBristol-Myers SquibbPhase 1

Daclatasvir-Sofosbuvir (Daclatasvir-Sofosbuvir)

Chronic Hepatitis C · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Phase1#Popular#cell-gene-therapy+3
Trials 56Status Active

5 / 68 pages

← PreviousNext →